학술논문

Exceptional response to the ataxia telangiectasia and Rad3-related inhibitor (ATRi), camonsertib, in a patient with alternative lengthening of telomeres (ALT)positive metastatic melanoma
Document Type
Journal
Source
CANCER RESEARCH; JAN 1 2024, 84 1, 2p. Supplement: S
Subject
Language
English
ISSN
15387445